SYSTEM FOR PREDICTING PROGNOSIS AND BENEFIT FROM ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH STAGE II AND III GASTRIC CANCER

摘要

The present invention relates to a system for predicting a post-surgery prognosis or anticancer drug compatibility of advanced gastric cancer patients. An algorithm capable of predicting the prognosis and anticancer drug compatibility of advanced gastric cancer by using quantitative test results of the mRNA expression levels of a marker gene cluster and a reference gene cluster for the prognosis or anticancer drug compatibility thereof is developed so as to be usable as supplementary information for determining a treatment method for gastric cancer patients.